|
1
|
Heusch G: Myocardial ischaemia-reperfusion
injury and cardioprotection in perspective. Nat Rev Cardiol.
17:773–789. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Davidson SM, Adameová A, Barile L,
Cabrera-Fuentes HA, Lazou A, Pagliaro P, Stensløkken KO and
Garcia-Dorado D: EU-CARDIOPROTECTION COST Action (CA16225).
Mitochondrial and mitochondrial-independent pathways of myocardial
cell death during ischaemia and reperfusion injury. J Cell Mol Med.
24:3795–3806. 2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Ren D, Wang X, Ha T, Liu L, Kalbfleisch J,
Gao X, Williams D and Li C: SR-A deficiency reduces myocardial
ischemia/reperfusion injury; involvement of increased microRNA-125b
expression in macrophages. Biochim Biophys Acta. 1832:336–346.
2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Cadenas S: ROS and redox signaling in
myocardial ischemia-reperfusion injury and cardioprotection. Free
Radic Biol Med. 117:76–89. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Granger DN and Kvietys PR: Reperfusion
injury and reactive oxygen species: The evolution of a concept.
Redox Biol. 6:524–551. 2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Bugger H and Pfeil K: Mitochondrial ROS in
myocardial ischemia reperfusion and remodeling. Biochim Biophys
Acta Mol Basis Dis. 1866(165768)2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Chen YR and Zweier JL: Cardiac
mitochondria and reactive oxygen species generation. Circ Res.
114:524–537. 2014.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Zorov DB, Juhaszova M and Sollott SJ:
Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS
release. Physiol Rev. 94:909–950. 2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Magenta A, Ciarapica R and Capogrossi MC:
The emerging role of miR-200 family in cardiovascular diseases.
Circ Res. 120:1399–1402. 2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Kalinina EV, Ivanova-Radkevich VI and
Chernov NN: Role of MicroRNAs in the regulation of redox-dependent
processes. Biochemistry (Mosc). 84:1233–1246. 2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Magenta A, Lorde R, Syed SB, Capogrossi
MC, Puca A and Madeddu P: Molecular therapies delaying
cardiovascular aging: Disease- or health-oriented approaches. Vasc
Biol. 2:R45–R58. 2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Qadir MMF, Klein D, Álvarez-Cubela S,
Domínguez-Bendala J and Pastori RL: The role of MicroRNAs in
diabetes-related oxidative stress. Int J Mol Sci.
20(5423)2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Yao B, Wan X, Zheng X, Zhong T, Hu J, Zhou
Y, Qin A, Ma Y and Yin D: Critical roles of microRNA-141-3p and
CHD8 in hypoxia/reoxygenation-induced cardiomyocyte apoptosis. Cell
Biosci. 10(20)2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Qin Q, Cui L, Zhou Z, Zhang Z, Wang Y and
Zhou C: Inhibition of microRNA-141-3p reduces hypoxia-induced
apoptosis in H9c2 rat cardiomyocytes by activating the
RP105-dependent PI3K/AKT signaling pathway. Med Sci Monit.
25:7016–7025. 2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Zheng Y, Dong L, Liu N, Luo X and He Z:
Mir-141-3p regulates apoptosis and mitochondrial membrane potential
via targeting sirtuin1 in a 1-methyl-4-phenylpyridinium in vitro
model of Parkinson's disease. Biomed Res Int.
2020(7239895)2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Baseler WA, Thapa D, Jagannathan R,
Dabkowski ER, Croston TL and Hollander JM: miR-141 as a regulator
of the mitochondrial phosphate carrier (Slc25a3) in the type 1
diabetic heart. Am J Physiol Cell Physiol. 303:C1244–C1251.
2012.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Delavar MR, Baghi M, Safaeinejad Z,
Kiani-Esfahani A, Ghaedi K and Nasr-Esfahani MH: Differential
expression of miR-34a, miR-141, and miR-9 in MPP+-treated
differentiated PC12 cells as a model of Parkinson's disease. Gene.
662:54–65. 2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Zhang J, Ren D, Fedorova J, He Z and Li J:
SIRT1/SIRT3 modulates redox homeostasis during ischemia/reperfusion
in the aging heart. Antioxidants (Basel). 9(858)2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Lee IH: Mechanisms and disease
implications of sirtuin-mediated autophagic regulation. Exp Mol
Med. 51:1–11. 2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Filadi R, Pendin D and Pizzo P: Mitofusin
2: From functions to disease. Cell Death Dis. 9(330)2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Olmedo I, Pino G, Riquelme JA, Aranguiz P,
Díaz MC, López-Crisosto C, Lavandero S, Donoso P, Pedrozo Z and
Sánchez G: Inhibition of the proteasome preserves Mitofusin-2 and
mitochondrial integrity, protecting cardiomyocytes during
ischemia-reperfusion injury. Biochim Biophys Acta Mol Basis Dis.
1866(165659)2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Chun SK, Lee S, Flores-Toro J, Rebecca YU,
Yang MJ, Go KL, Biel TG, Miney CE, Louis SP, Law BK, et al: Loss of
sirtuin 1 and mitofusin 2 contributes to enhanced
ischemia/reperfusion injury in aged livers. Aging Cell.
17(e12761)2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Biel TG, Lee S, Flores-Toro JA, Dean JW,
Go KL, Lee MH, Law BK, Law ME, Dunn WA Jr, Zendejas I, et al:
Sirtuin 1 suppresses mitochondrial dysfunction of ischemic mouse
livers in a mitofusin 2-dependent manner. Cell Death Differ.
23:279–290. 2016.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Liu Y, Nguyen P, Baris TZ and Poirier MC:
Molecular analysis of mitochondrial compromise in rodent
cardiomyocytes exposed long term to nucleoside reverse
transcriptase inhibitors (NRTIs). Cardiovasc Toxicol. 12:123–134.
2012.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Poli G, Guasti D, Rapizzi E, Fucci R, Canu
L, Bandini A, Cini N, Bani D, Mannelli M and Luconi M:
Morphofunctional effects of mitotane on mitochondria in human
adrenocortical cancer cells. Endocr Relat Cancer. 20:537–550.
2013.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Magenta A, Cencioni C, Fasanaro P,
Zaccagnini G, Greco S, Sarra-Ferraris G, Antonini A, Martelli F and
Capogrossi MC: miR-200c is upregulated by oxidative stress and
induces endothelial cell apoptosis and senescence via ZEB1
inhibition. Cell Death Differ. 18:1628–1639. 2011.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Tamura M, Sasaki Y, Kobashi K, Takeda K,
Nakagaki T, Idogawa M and Tokino T: CRKL oncogene is downregulated
by p53 through miR-200s. Cancer Sci. 106:1033–1040. 2015.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Xiao Y, Yan W, Lu L, Wang Y, Lu W, Cao Y
and Cai W: p38/p53/miR-200a-3p feedback loop promotes oxidative
stress-mediated liver cell death. Cell Cycle. 14:1548–1558.
2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Du JK, Cong BH, Yu Q, Wang H, Wang L, Wang
CN, Tang XL, Lu JQ, Zhu XY and Ni X: Upregulation of microRNA-22
contributes to myocardial ischemia-reperfusion injury by
interfering with the mitochondrial function. Free Radic Biol Med.
96:406–417. 2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
D'Onofrio N, Servillo L and Balestrieri
ML: SIRT1 and SIRT6 signaling pathways in cardiovascular disease
protection. Antioxid Redox Signal. 28:711–732. 2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Elibol B and Kilic U: High levels of SIRT1
expression as a protective mechanism against disease-related
conditions. Front Endocrinol (Lausanne). 9(614)2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Hsu CP, Zhai P, Yamamoto T, Maejima Y,
Matsushima S, Hariharan N, Shao D, Takagi H, Oka S and Sadoshima J:
Silent information regulator 1 protects the heart from
ischemia/reperfusion. Circulation. 122:2170–2182. 2010.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Xiong W, Ma Z, An D, Liu Z, Cai W, Bai Y,
Zhan Q, Lai W, Zeng Q, Ren H and Xu D: Mitofusin 2 participates in
mitophagy and mitochondrial fusion against angiotensin II-induced
cardiomyocyte injury. Front Physiol. 10(411)2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Mouchiroud L, Houtkooper RH, Moullan N,
Katsyuba E, Ryu D, Cantó C, Mottis A, Jo YS, Viswanathan M,
Schoonjans K, et al: The NAD(+)/sirtuin pathway modulates longevity
through activation of mitochondrial UPR and FOXO signaling. Cell.
154:430–441. 2013.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Zhou Z, Ma D, Li P, Wang P, Liu P, Wei D,
Wang J, Qin Z, Fang Q, Wang J, et al: Sirt1 gene confers Adriamycin
resistance in DLBCL via activating the PCG-1α mitochondrial
metabolic pathway. Aging (Albany NY). 12:11364–11385.
2020.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Hu L, Guo Y, Song L, Wen H, Sun N, Wang Y,
Qi B, Liang Q, Geng J, Liu X, et al: Nicotinamide riboside promotes
Mfn2-mediated mitochondrial fusion in diabetic hearts through the
SIRT1-PGC1α-PPARα pathway. Free Radical Biol Med. 183:75–88.
2022.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Soriano FX, Liesa M, Bach D, Chan DC,
Palacín M and Zorzano A: Evidence for a mitochondrial regulatory
pathway defined by peroxisome proliferator-activated receptor-gamma
coactivator-1 alpha, estrogen-related receptor-alpha, and mitofusin
2. Diabetes. 55:1783–1791. 2006.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Sabouny R and Shutt TE: Reciprocal
regulation of mitochondrial fission and fusion. Trends Biochem Sci.
45:564–577. 2020.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Liu YJ, McIntyre RL, Janssens GE and
Houtkooper RH: Mitochondrial fission and fusion: A dynamic role in
aging and potential target for age-related disease. Mech Ageing
Dev. 186(111212)2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Tao A, Xu X, Kvietys P, Kao R, Martin C
and Rui T: Experimental diabetes mellitus exacerbates
ischemia/reperfusion-induced myocardial injury by promoting
mitochondrial fission: Role of down-regulation of myocardial Sirt1
and subsequent Akt/Drp1 interaction. Int J Biochem Cell Biol.
105:94–103. 2018.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Fu BC, Lang JL, Zhang DY, Sun L, Chen W,
Liu W, Liu KY, Ma CY, Jiang SL, Li RK and Tian H: Suppression of
miR-34a expression in the myocardium protects against
ischemia-reperfusion injury through SIRT1 protective pathway. Stem
Cells Dev. 26:1270–1282. 2017.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Liu P, Su J, Song X and Wang S: miR-92a
regulates the expression levels of matrix metalloproteinase 9 and
tissue inhibitor of metalloproteinase 3 via sirtuin 1 signaling in
hydrogen peroxide-induced vascular smooth muscle cells. Mol Med
Rep. 17:1041–1048. 2018.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Bae HJ, Noh JH, Kim JK, Eun JW, Jung KH,
Kim MG, Chang YG, Shen Q, Kim SJ, Park WS, et al: MicroRNA-29c
functions as a tumor suppressor by direct targeting oncogenic SIRT1
in hepatocellular carcinoma. Oncogene. 33:2557–2567.
2014.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Purohit PK, Edwards R, Tokatlidis K and
Saini N: MiR-195 regulates mitochondrial function by targeting
mitofusin-2 in breast cancer cells. RNA Biol. 16:918–929.
2019.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Zhang C, Nie P, Zhou C, Hu Y, Duan S, Gu
M, Jiang D, Wang Y, Deng Z, Chen J, et al: Oxidative stress-induced
mitophagy is suppressed by the miR-106b-93-25 cluster in a
protective manner. Cell Death Dis. 12(209)2021.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Qiu Y, Cheng R, Liang C, Yao Y, Zhang W,
Zhang J, Zhang M, Li B, Xu C and Zhang R: MicroRNA-20b promotes
cardiac hypertrophy by the inhibition of mitofusin 2-mediated
inter-organelle Ca(2+) cross-talk. Mol Ther Nucleic Acids.
19:1343–1356. 2020.PubMed/NCBI View Article : Google Scholar
|
